Investing Profile

Daniel Bradbury

InvestorVCFounderAngel
Chairman of the Board and Chief Executive Officer at Equillium, Inc.
biobrit.com/management/San Diego, California
Photo of Daniel Bradbury, Equillium, Inc.

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
UCLA Anderson School of Management Network
129 CONNECTIONS
Mount Auburn Hospital Network
102 CONNECTIONS
University of Nottingham Network
43 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
CompanyStageDateRound SizeTotal Raised
Amplo Biotechnology
SeedOct 2021$2M
$2M
Alume Biosciences
Series AMay 2020$6M
$6M
Chairman of the Board Freedom Meditech Inc. -SOLDPresent
Director Renova TherapeuticsPresent
Board Observer SiteOne Therapeutics Inc.Present
Director Syngene International LimitedPresent
Chairman of the Board Thesan PharmaceuticalsPresent
Director Intercept PharmaceuticalsPresent
Chairman of the Board ADCY5.orgPresent
Chairman Of The Board NeuroViaPresent
Chairman Of The Board BiolinqPresent
Director Biocon BiologicsPresent
Director Synedgen, IncPresent
Director IQHQPresent
Executive Chairman Equillium, Inc.Present
Director Alume BiosciencesPresent
Board Observer Neuralace Medical®Present
Executive Chairman Mount Auburn HospitalPresent
Director Abilita Therapeutics, Inc.Present
Chairman of the Board Persephone BiomePresent
Director VivaniPresent
Chairman of the Board MinutiaPresent
Executive Chairman Alume BiosciencesPresent
Chairman of the Board Equillium, Inc.Present
Chairman of the Board Tavo BiotherapeuticsPresent
President and Chief Executive Officer Amylin PharmaceuticalsPresent
Chairman of the Board and Chief Executive Officer Equillium, Inc.Present
University of Nottingham Bachelor of Pharmacy (B.Pharm.) Pharmacy
Thames Valley University Diploma in Management Studies Business Administration and Management, General
UCLA Anderson School of Management Director Certification Program Corporate Governance
Sign in with Google →
Sign in with Google →